Spark Biomedical Awa
Spark Biomedical Awarded National Institute on Drug Abuse Funding to Develop AI-Algorithm for Opioid Withdrawal and Cravings Detection
September 12, 2024 13:39 ET | Spark Biomedical
Dallas, TX, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Spark Biomedical, a leader in wearable neurostimulation technology, is partnering with prestigious research and behavioral health institutes, Battelle...
Sparrow Link Research Platform
Spark Biomedical Introduces Sparrow Link: A Revolutionary Research Platform for Non-Invasive Neurostimulation
September 05, 2024 09:00 ET | Spark Biomedical
Dallas, TX, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Spark Biomedical, a global pioneer in wearable neurostimulation solutions, proudly announces the launch of Sparrow Link, a revolutionary research...
Lungpacer AeroPace PMA Submission Press Release
Lungpacer Medical Announces PMA Submission for AeroPace® System
September 04, 2024 09:00 ET | Lungpacer Medical USA Inc.
Lungpacer Medical today announced that its AeroPace System is under Food and Drug Administration (FDA) review in a premarket approval (PMA) application.
Behind the Scenes of
Behind the Scenes of Medical Innovation: Spark Biomedical launches new web series ‘Spark a Conversation’
July 01, 2024 09:48 ET | Spark Biomedical
Dallas, TX, July 01, 2024 (GLOBE NEWSWIRE) -- For as long as there has been opioid use disorder, there have only been two solutions: cold turkey or more drugs. The founders of Spark Biomedical...
22157.jpg
Neurotechnology Research Report 2024: Market Set to Surge, North America Leads Growth Trajectory - Long-term Forecast to 2028 and 2033
January 30, 2024 10:49 ET | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Neurotechnology Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The report reveals that the neurotechnology...
Global Neurostimulation Market
Global Neurostimulation Technology and Market Research Report 2023 Featuring Major Players - Axonics, Boston Scientific, Medtronic, Synapse Biomedical, and Xavant Technology
December 13, 2023 07:23 ET | Research and Markets
Dublin, Dec. 13, 2023 (GLOBE NEWSWIRE) -- The "Neurostimulation: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. This report provides a comprehensive...
Future Market Insights.png
Neurostimulation Market Surges with a Promising CAGR of 9.5% through 2033, Projected to Reach a Valuation of US$ 15,417.4 Million | Future Market Insights Inc.
November 14, 2023 12:00 ET | Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, DEL, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The global neurostimulation market value is expected to rise from US$ 6,221.2 million in 2023 to US$ 15,417.4 million by 2033. This estimated growth is...
22157.jpg
Global Neurostimulation Devices Market Expected to Reach $11.34 Billion by 2028: Players Include Medtronic, Cyberonics, Boston Scientific and Abbott Laboratories
October 16, 2023 05:38 ET | Research and Markets
Dublin, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The "Neurostimulation Devices - Global Market Insights, Competitive Landscape, and Market Forecast - 2028" report has been added to ...
TIP_link_300x300.jpg
Neurostimulation Devices Market 2023 Report - Reach $11.82 Billion, Globally, by 2030 - Comprehensive Report by The Insight Partners
October 04, 2023 10:32 ET | The Insight Partners
Pune, India, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Neurostimulation devices attach electrodes to the brain, spinal cord, or peripheral nerves. Each device can collect and store data over time, and the...
ONWARD_Logotype®_Red.png
ONWARD® Announces First-in-Human Implant of ARC-IM™ Stimulator with Brain-Computer Interface (BCI) to Restore Arm, Hand, and Finger Function after Spinal Cord Injury
September 27, 2023 01:30 ET | ONWARD Medical NV
Eindhoven, Sept. 27, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement,...